Fernwood Investment Management, LLC Blueprint Medicines Corp Transaction History

Fernwood Investment Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$73.17 - $99.79 $29,560 - $40,315	404 New	404 $38,000
Q4 2018 Feb 12, 2019	SELL	$45.57 - $74.26 $122,856 - $200,204	-2,696 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$58.91 - $78.32 $158,821 - $211,150	2,696 New	2,696 $210,000
Q2 2018 Aug 14, 2018	SELL	$60.96 - $101.18 $164,348 - $272,781	-2,696 Closed	0 $0
Q1 2018 May 03, 2018	SELL	$73.28 - $102.95 $82,073 - $115,304	-1,120 Reduced 29.35%	2,696 $247,000
Q3 2017 Nov 09, 2017	BUY	$42.37 - $69.67 $161,683 - $265,860	3,816	3,816 $266,000

350

60.3M

2.25M

1.18M

Ticker BPMC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,719,600
Market Cap $6.57B
Description
Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...

Get notified when there are updates to the investment portfolio of Fernwood Investment Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fernwood Investment Management, LLC with notifications on news.